Chinese english Germany Japanese Korea

Voreloxin

Voreloxin Struktur
175414-77-4
CAS-Nr.
175414-77-4
Englisch Name:
Voreloxin
Synonyma:
SPC-595;SNS-595;AG-7352;CS-1489;VOSAROXIN;Voreloxin;Voreloxin, >=98%;Voreloxin (SNS-595);Voreloxin USP/EP/BP;SNS-595; VOSAROXIN; AG 7352
CBNumber:
CB92538816
Summenformel:
C18H19N5O4S
Molgewicht:
401.44
MOL-Datei:
175414-77-4.mol
Request For Quotation

Voreloxin Eigenschaften

Siedepunkt:
652.0±65.0 °C(Predicted)
Dichte
1.52±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
insoluble in H2O; insoluble in EtOH; insoluble in DMSO
Aggregatzustand
solid
pka
5.68±0.70(Predicted)

Sicherheit

Voreloxin Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Voreloxin is a potent Topoisomerase II inhibitor with broad-spectrum anti-tumor activity.

Voreloxin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Voreloxin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 61)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED 		+undefined-21-51877795
ivan@atkchemical.com China 32480 60
career henan chemical co 		+86-0371-86658258
sales@coreychem.com China 29914 58
Chongqing Chemdad Co., Ltd 		+86-023-61398051 +8613650506873
 sales@chemdad.com China 39916 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD 		86-571-88216897,88216896 13588875226
 sales@hzclap.com CHINA 6313 58
Dideu Industries Group Limited 		+86-29-89586680 +86-15129568250
 1026@dideu.com China 29220 58
Baoji Guokang Bio-Technology Co., Ltd. 		0917-3909592 13892490616
 gksales1@gk-bio.com China 9339 58
Zhejiang J&C Biological Technology Co.,Limited 		+1-2135480471 +1-2135480471
 sales@sarms4muscle.com China 10523 58
TargetMol Chemicals Inc. 		+1-781-999-5354
support@targetmol.com United States 19973 58
ShenZhen Trendseen Biological Technology Co.,Ltd. 		13417589054
 trendseenbio@gmail.com China 11681 58
Wuhan Topule Biopharmaceutical Co., Ltd 		+8618327326525
 masar@topule.com China 8474 58
  • 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo -1-(2-thiazolyl)-
  • Voreloxin (SNS-595)
  • Voreloxin, >=98%
  • Voreloxin
  • AG-7352
  • SNS-595
  • SPC-595
  • AG-7352, 1,4-dihydro-7-[(S,S)-3-Methoxy-4-MethylaMino-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic, (+)-1,4-dihydro-7-[(3S,4S)-3-Methoxy-4-(MethylaMino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
  • VOSAROXIN
  • 7-((3S,4S)-3-Methoxy-4-(MethylaMino)pyrrolidin-1-yl)-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
  • 1,4-Dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
  • 7-[(3S,4S)-3-methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid
  • SNS-595; VOSAROXIN; AG 7352
  • CS-1489
  • Voreloxin USP/EP/BP
  • 175414-77-4
  • API
  • Inhibitors
Copyright 2019 © ChemicalBook. All rights reserved